TICKERNERD
Menu
ASPNASPNBasic Materials · Specialty Chemicals

ASPN Stock Forecast: Aspen Aerogels, Inc. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$5.85
−3.62% on the day

The 6 Wall Street analysts covering Aspen Aerogels, Inc. hold a median 12-month price target of $7.75 — +32.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 60 of 100 as at 15 Aug 2026 — in the upper half.

Market cap
$485.5M
Ticker Nerd rank
60 / 100
Median analyst target
$7.75
Analysts covering
6
Total return, dividends reinvested
1W
−6.4%
1M
+11.0%
YTD
+106.7%
1Y
−17.1%
From 52W high
−33.7%
From 52W low
+127.6%
$2.57
$8.82
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ASPN stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Aspen Aerogels, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 15 Aug 2026
60 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
100
Issuance
83
Revisions
81
Size
54
Value
39
Quality
38
Momentum
31
Growth
29
Volatility
6

Accruals (100): Reported profit is backed by cash, and the company is not expanding recklessly.

Volatility (6): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ASPN stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ASPN, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$2.00$4.00$6.00$8.00$10.00Oct 25Jan 26Apr 26Jul 26ASPNHigh $10.00Median $7.75Low $5.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says6 analysts
4 Buy1 Hold1 Sell
Low $5.00Median $7.75High $10.00

The green dot is the last close — the median target sits +32.5% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
11 Aug 2026BarclaysMaintainsUnderweight$4.00 → $5.00
11 May 2026BarclaysMaintainsUnderweight$3.00 → $4.00
11 May 2026BarclaysMaintainsUnderweight—
5 Mar 2026BarclaysMaintainsUnderweight—
26 Feb 2026Roth CapitalMaintainsBuy—
26 Feb 2026TD CowenMaintainsBuy—
7 Nov 2025BarclaysMaintainsUnderweight—
7 Nov 2025Canaccord GenuityMaintainsBuy—
11 Aug 2025BarclaysDowngradeUnderweight—
8 Aug 2025Canaccord GenuityMaintainsBuy—
29 May 2025BarclaysDowngradeEqual-Weight—
19 Feb 2025B. Riley SecuritiesMaintainsBuy—
19 Feb 2025BarclaysMaintainsOverweight—
14 Feb 2025Canaccord GenuityMaintainsBuy—
14 Feb 2025Craig-HallumMaintainsBuy—
14 Feb 2025Roth MKMMaintainsBuy—
13 Feb 2025Seaport GlobalDowngradeNeutral—
24 Jan 2025Craig-HallumMaintainsBuy—
16 Jan 2025Canaccord GenuityMaintainsBuy—
12 Nov 2024BarclaysMaintainsOverweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ASPN appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

ASPN analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
3
Analysts cutting
0
Fundamentals

Aspen Aerogels, Inc. (ASPN) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
25.4×

Cheaper than 32% of US stocks

Price / sales
2.4×

Cheaper than 48% of US stocks

Price / book
2.5×

Cheaper than 40% of US stocks

EV / EBITDA
−11.2×

Cheaper than 85% of US stocks

Growth & margins
Revenue growth (YoY)
−36.1%

Higher than 7% of US stocks

Earnings growth (YoY)
−51.9%

Higher than 10% of US stocks

Gross margin
11.3%

Higher than 11% of US stocks

Operating margin
−29.2%

Higher than 19% of US stocks

Net margin
−62.4%

Higher than 9% of US stocks

Returns & dividend
Return on equity
−50.4%

Higher than 21% of US stocks

Return on assets
−8.4%

Higher than 27% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

ASPN vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSpecialty Chemicals
CompanyMarket capTKN rank
ASPNAspen Aerogels, Inc.$485.5M
60
GEVOGevo, Inc.$411.4M
56
OECOrion SA$361.6M
55
MATVMativ Holdings, Inc.$673.0M
90
ALTOAlto Ingredients, Inc.$323.3M
99
MNTKMontauk Renewables, Inc.$267.4M
42
KOPKoppers Holdings, Inc.$924.6M
89

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Aspen Aerogels, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ASPN news & analysis

Aspen Aerogels: Green Shoots Fail To Truly Impress Investors

Seeking Alpha · 10 Aug 2026neutral

Aspen Aerogels posted sequential revenue and EBITDA gains, with Q2 revenue exceeding guidance and Q3 outlook indicating further recovery, although shares failed to truly impress investors. Thermal Barrier sales rebounded sequentially, especially in Europe, but remain pressured by regulatory shifts and evolving battery technologies, while its EBITDA break-even threshold was lowered to $175 million in annual revenue.

Why it matters — ASPN watchers would care because the report shows operational progress and a lower break-even threshold, yet continuing headwinds in the Thermal Barrier segment and an underwhelming market reaction signal a mixed outlook for the company.

Aspen Aerogels Reminds Us Materials Science Can Be Cool, Especially If EVs Are Hot

Seeking Alpha · 10 Aug 2026neutral

A Seeking Alpha article by an author discusses materials science as an underappreciated field, using Aspen Aerogels as an example of a company whose products could matter if electric vehicles become more popular. The piece frames materials science as less glamorous than AI or consumer tech but nonetheless relevant.

Why it matters — For ASPN watchers, the article highlights the company's connection to the electric vehicle theme, which could shape how investors perceive its long-term opportunity.

Aspen Aerogels Q2 Earnings Call Highlights

MarketBeat · 7 Aug 2026positive

Aspen Aerogels said during its Q2 earnings call that it expects a sharp sequential increase in revenue and adjusted EBITDA in the third quarter. The growth is expected to be supported by energy-industrial project deliveries, rising General Motors EV production, and expanding European demand for its PyroThin thermal barriers.

Why it matters — The company's guidance signals near-term growth for ASPN, driven by energy-industrial, automotive, and European thermal-barrier demand.

Aspen Aerogels, Inc. (ASPN) Q2 2026 Earnings Call Transcript

Seeking Alpha · 7 Aug 2026neutral

Aspen Aerogels held its Q2 2026 earnings call, and the transcript of that call was published on Seeking Alpha.

Why it matters — Earnings call transcripts provide direct insight into management's commentary and financial results, which can influence investor views on Aspen Aerogels' performance and outlook.

Aspen Aerogels (ASPN) Reports Q2 Loss, Beats Revenue Estimates

Zacks Investment Research · 6 Aug 2026neutral

Aspen Aerogels reported a Q2 loss of $0.22 per share, in line with the Zacks Consensus Estimate and wider than the $0.04 per-share loss a year ago. According to the headline, the company beat revenue estimates.

Why it matters — APSN watchers would care because the company widened its quarterly loss versus last year even as it beat revenue expectations and matched the consensus loss estimate.

FAQ

Frequently asked questions about ASPN stock

What is the ASPN stock price forecast for 2026-2027?

The 6 Wall Street analysts covering Aspen Aerogels, Inc. have a median 12-month price target of $7.75, with estimates ranging from $5 to $10. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ASPN stock a buy right now?

Of the 6 analysts covering Aspen Aerogels, Inc., 4 rate it a Buy, 1 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Aspen Aerogels, Inc. 60 out of 100 across roughly 4,600 US stocks as at 15 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ASPN?

As at 15 Aug 2026, Aspen Aerogels, Inc. ranks 60 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (100 of 100).

Will ASPN stock go up?

No one can know that. What the data says: the median 12-month target from 6 analysts implies +32.5% from the last close, and Ticker Nerd's factor model ranks Aspen Aerogels, Inc. 60 out of 100 as at 15 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ASPN stock forecast for 2030?

No analyst covering Aspen Aerogels, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ASPN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $5 to $10 over the next 12 months.

How has ASPN stock performed over the past year?

Aspen Aerogels, Inc. returned -17.1% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Aspen Aerogels, Inc. do?

Aspen Aerogels Inc. is a technology company specializing in the design, development, and manufacture of advanced aerogel materials.

What is the latest news on ASPN?

The most recent item we track (Seeking Alpha, 10 Aug 2026): "Aspen Aerogels: Green Shoots Fail To Truly Impress Investors". Aspen Aerogels posted sequential revenue and EBITDA gains, with Q2 revenue exceeding guidance and Q3 outlook indicating further recovery, although shares failed to truly impress investors. Thermal Barrier sales rebounded sequentially, especially in Europe, but remain pressured by regulatory shifts and evolving battery technologies, while its EBITDA break-even threshold was lowered to $175 million in annual revenue.

Company

About Aspen Aerogels, Inc.

Aspen Aerogels Inc. is a technology company specializing in the design, development, and manufacture of advanced aerogel materials. These materials are primarily used for thermal management solutions in a variety of industries, including energy infrastructure, petrochemical, and building materials. Known for their lightweight nature and exceptional insulating properties, aerogels produced by Aspen Aerogels play a critical role in enhancing energy efficiency and reducing carbon footprints. Within the industrial sector, their applications are vital for controlling process temperatures and maintaining operational safety. In the building industry, these materials contribute to the development of energy-efficient structures. Based in Northborough, Massachusetts, Aspen Aerogels’ innovations in nanotechnology make it a significant player in the advancement of sustainable and energy-efficient technologies. The company's focus on cutting-edge insulation solutions aligns with growing global demands for energy conservation and climate change mitigation, highlighting its continued relevance in the market.

CEO Mr. Donald R. Young · 854 employees · United States · https://www.aerogel.com